Alerts will be sent to your verified email
Verify EmailBDH
|
BDH Inds
|
Lyka Labs
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.8 % | 68.98 % | 16.56 % |
|
5yr average Equity Multiplier
|
1.46 | 2.9 | -1.71 |
|
5yr Average Asset Turnover Ratio
|
0.89 | 0.73 | 1.26 |
|
5yr Avg Net Profit Margin
|
11.59 % | -0.79 % | -10.07 % |
|
Price to Book
|
3.04 | 2.18 | 0.0 |
|
P/E
|
20.59 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
-27.79 Days | 32.55 Days | -21.7 Days |
|
Inventory Days
|
31.79 Days | 24.2 Days | 80.38 Days |
|
Days Receivable
|
116.74 Days | 92.33 Days | 20.8 Days |
|
Days Payable
|
156.43 Days | 106.74 Days | 154.17 Days |
|
5yr Average Interest Coverage Ratio
|
78.47 | 2.2 | -3.16 |
|
5yr Avg ROCE
|
19.81 % | 25.83 % | -3.19 % |
|
5yr Avg Operating Profit Margin
|
14.91 % | 24.02 % | -9.3 % |
|
5 yr average Debt to Equity
|
0.1 | 1.25 | -1.91 |
|
5yr CAGR Net Profit
|
7.83 % | n/a | n/a |
|
5yr Average Return on Assets
|
10.19 % | 1.72 % | -6.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.7 % | 58.16 % | 56.54 % |
|
Share Pledged by Promoters
|
8.99 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.04 % | 7.16 % | 47.55 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -3.3 % | -0.04 % |
|
BDH Inds
|
Lyka Labs
|
Oxygenta Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|